Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.12), $0.08 better than the analyst estimate of ($0.20).“We continue to execute ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE